COM:REVMED
Revolution Medicines
- Stock
Last Close
56.78
22/11 21:00
Market Cap
7.01B
Beta: -
Volume Today
1.17M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 3.30M - | 3.30M 0% | -6.36M - | -6.36M 0% | 0.50 100.00% | |||
average payables | 4.29M - | 8.32M 93.69% | 12.00M 44.32% | 13.33M 11.07% | 17.68M 32.61% | 41.55M 134.97% | ||
average receivables | 3.65M - | 8.02M 119.64% | 7.57M 5.67% | 6.16M 18.56% | 5.30M 13.96% | 2.96M 44.10% | ||
book value per share | 0.12 - | 2.65 2,033.28% | 2.88 8.80% | 8.65 200.01% | 8.28 4.32% | 8.50 2.68% | 0.02 99.81% | |
capex per share | -0.04 - | -0.04 4.83% | -0.05 19.08% | -0.05 9.22% | -0.09 67.75% | -0.13 49.62% | -0.00 99.95% | |
capex to depreciation | -1.33 - | -0.85 35.90% | -0.77 8.84% | -0.45 42.15% | -0.89 98.68% | -1.12 25.81% | -1.26 12.93% | |
capex to operating cash flow | 0.06 - | -1.24 2,073.17% | 0.05 104.22% | 0.03 43.83% | 0.04 51.32% | 0.05 8.67% | 0.02 54.26% | |
capex to revenue | -0.07 - | -0.05 30.40% | -0.07 31.89% | -0.22 225.51% | -0.31 37.63% | -0.67 118.33% | ||
cash per share | 0.25 - | 1.91 666.45% | 2.32 21.63% | 8.03 246.13% | 7.93 1.32% | 8.00 0.92% | 0.02 99.80% | |
days of inventory on hand | ||||||||
days payables outstanding | ||||||||
days sales outstanding | 132.19 - | 63.73 51.79% | 54.29 14.81% | 73.63 35.64% | 48.21 34.53% | 39.53 18.01% | ||
debt to assets | 0.01 - | 0.01 38.37% | 0.06 563.64% | 0.09 56.84% | 0.08 12.42% | 0.04 46.06% | ||
debt to equity | 0.02 - | 0.01 49.51% | 0.07 448.69% | 0.11 60.70% | 0.09 15.26% | 0.05 48.61% | ||
dividend yield | ||||||||
earnings yield | -0.03 - | -0.04 34.25% | -0.03 21.36% | -0.05 59.70% | -0.10 97.04% | -0.13 32.01% | -0.00 99.90% | |
enterprise value | 1.04B - | 984.63M 5.78% | 1.51B 53.60% | 2.10B 38.91% | 1.79B 14.77% | 1.82B 1.82% | 3.24T 177,846.59% | |
enterprise value over ebitda | -35.02 - | -24.67 29.56% | -31.13 26.16% | -19.37 37.77% | -9.57 50.59% | -7.32 23.54% | -6.66K 90,894.06% | |
ev to operating cash flow | -41.55 - | 811.73 2,053.46% | -30.48 103.76% | -21.00 31.12% | -12.17 42.05% | -8.13 33.22% | -9.25K 113,803.54% | |
ev to sales | 48.83 - | 30.22 38.10% | 48.88 61.72% | 60.93 24.66% | 51.54 15.42% | 280.18K 543,574.46% | ||
free cash flow per share | -0.73 - | -0.01 98.93% | -0.99 12,484.74% | -1.88 90.20% | -2.11 12.48% | -2.92 38.19% | -0.00 99.89% | |
free cash flow yield | -0.03 - | -0.00 98.93% | -0.03 12,484.74% | -0.05 38.85% | -0.08 76.92% | -0.12 46.02% | -0.00 99.91% | |
graham net net | -0.04 - | 0.12 402.30% | 1.16 853.25% | 6.43 454.71% | 6.04 6.06% | 6.47 7.14% | 0.01 99.78% | |
graham number | 1.54 - | 8.27 435.16% | 7.65 7.50% | 19.59 156.19% | 21.44 9.48% | 24.29 13.26% | 0.04 99.85% | |
income quality | 0.81 - | -0.03 103.59% | 1.04 3,686.18% | 0.93 11.12% | 0.79 14.97% | 0.90 14.69% | 0.80 10.96% | |
intangibles to total assets | 0 - | 0.46 Infinity% | 0.35 23.71% | 0.13 61.68% | 0.10 24.20% | 0.09 10.41% | 0.04 61.19% | |
interest coverage | -302.22 - | -347.66 15.04% | -510.57 46.86% | -1.56K 205.37% | -15.67K 904.89% | 26.75 100.17% | 1.61K 5,911.18% | |
interest debt per share | 0.00 - | 0.07 2,343.69% | 0.04 44.70% | 0.60 1,463.09% | 0.92 53.45% | 0.68 26.09% | 0.00 99.89% | |
inventory turnover | ||||||||
invested capital | 0.02 - | 0.01 49.51% | 0.07 448.69% | 0.11 60.70% | 0.09 15.26% | 0.05 48.61% | ||
market cap | 1.05B - | 1.05B 0% | 1.53B 45.04% | 2.17B 42.10% | 1.83B 15.65% | 1.92B 4.80% | 3.25T 168,871.52% | |
net current asset value | -1.10M - | 11.50M 1,141.09% | 65.99M 473.60% | 361.40M 447.68% | 441.63M 22.20% | 533.44M 20.79% | 1.64B 208.14% | |
net debt to ebitda | 0.30 - | 1.74 471.79% | 0.34 80.50% | 0.66 94.57% | 0.22 66.10% | 0.39 74.37% | 1.25 219.94% | |
net income per share | -0.85 - | -1.15 34.25% | -0.90 21.36% | -1.97 118.77% | -2.47 25.27% | -3.08 24.93% | -0.00 99.87% | |
operating cash flow per share | -0.69 - | 0.03 104.82% | -0.94 2,920.07% | -1.82 94.43% | -2.02 10.86% | -2.78 37.68% | -0.00 99.89% | |
payables turnover | ||||||||
receivables turnover | 2.76 - | 5.73 107.43% | 6.72 17.39% | 4.96 26.27% | 7.57 52.74% | 9.23 21.97% | ||
research and ddevelopement to revenue | 2.53 - | 1.83 27.62% | 3.08 67.80% | 6.36 106.74% | 7.15 12.45% | 36.54 410.85% | ||
return on tangible assets | -2.06 - | -0.45 78.21% | -0.33 26.37% | -0.22 33.61% | -0.27 23.21% | -0.34 24.29% | -0.22 34.87% | |
revenue per share | 0.55 - | 0.95 71.09% | 0.78 17.19% | 0.40 48.46% | 0.44 8.70% | 0.00 99.98% | ||
roe | -6.87 - | -0.43 93.71% | -0.31 27.72% | -0.23 27.08% | -0.30 30.93% | -0.36 21.66% | -0.24 34.17% | |
roic | -6.89 - | -0.39 94.29% | -0.32 18.51% | -0.20 36.28% | -0.25 20.17% | -0.32 29.09% | -0.25 22.60% | |
sales general and administrative to revenue | 0.47 - | 0.25 46.87% | 0.50 101.08% | 1.04 107.83% | 1.15 10.72% | 6.53 469.27% | ||
shareholders equity per share | 0.12 - | 2.65 2,033.28% | 2.88 8.80% | 8.65 200.01% | 8.28 4.32% | 8.50 2.68% | 0.02 99.81% | |
stock based compensation to revenue | 0.04 - | 0.06 48.98% | 0.21 227.27% | 0.71 241.09% | 0.88 25.05% | 5.33 504.98% | ||
tangible asset value | 4.53M - | 18.97M 318.65% | 75.91M 300.20% | 399.12M 425.76% | 528.08M 32.31% | 611.77M 15.85% | 1.75B 186.68% | |
tangible book value per share | 0.12 - | 0.52 318.65% | 1.43 175.92% | 7.27 406.86% | 7.25 0.28% | 7.59 4.61% | 0.02 99.80% | |
working capital | 1.84M - | 54.88M 2,877.70% | 90.93M 65.69% | 406.95M 347.54% | 558.12M 37.15% | 598.20M 7.18% | 1.74B 190.11% |
All numbers in USD (except ratios and percentages)